Global Ipilimumab Sales Market Report 2016

November 2016 | 109 pages | ID: GD3D94F9D09EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ipilimumab

Revenue, means the sales value of Ipilimumab

This report studies sales (consumption) of Ipilimumab in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer
• Novartis
• Bayer
• Roche
• Bristol-Myers Squibb
• Merck & Co.
• Exelixis

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Ipilimumab in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Ipilimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Ipilimumab Sales Market Report 2016

1 IPILIMUMAB OVERVIEW

1.1 Product Overview and Scope of Ipilimumab
1.2 Classification of Ipilimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Ipilimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Ipilimumab Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Ipilimumab (2011-2021)
  1.5.1 Global Ipilimumab Sales and Growth Rate (2011-2021)
  1.5.2 Global Ipilimumab Revenue and Growth Rate (2011-2021)

2 GLOBAL IPILIMUMAB COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Ipilimumab Market Competition by Manufacturers
  2.1.1 Global Ipilimumab Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Ipilimumab Revenue and Share by Manufacturers (2011-2016)
2.2 Global Ipilimumab (Volume and Value) by Type
  2.2.1 Global Ipilimumab Sales and Market Share by Type (2011-2016)
  2.2.2 Global Ipilimumab Revenue and Market Share by Type (2011-2016)
2.3 Global Ipilimumab (Volume and Value) by Regions
  2.3.1 Global Ipilimumab Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Ipilimumab Revenue and Market Share by Regions (2011-2016)
2.4 Global Ipilimumab (Volume) by Application

3 UNITED STATES IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 United States Ipilimumab Sales and Value (2011-2016)
  3.1.1 United States Ipilimumab Sales and Growth Rate (2011-2016)
  3.1.2 United States Ipilimumab Revenue and Growth Rate (2011-2016)
  3.1.3 United States Ipilimumab Sales Price Trend (2011-2016)
3.2 United States Ipilimumab Sales and Market Share by Manufacturers
3.3 United States Ipilimumab Sales and Market Share by Type
3.4 United States Ipilimumab Sales and Market Share by Application

4 CHINA IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 China Ipilimumab Sales and Value (2011-2016)
  4.1.1 China Ipilimumab Sales and Growth Rate (2011-2016)
  4.1.2 China Ipilimumab Revenue and Growth Rate (2011-2016)
  4.1.3 China Ipilimumab Sales Price Trend (2011-2016)
4.2 China Ipilimumab Sales and Market Share by Manufacturers
4.3 China Ipilimumab Sales and Market Share by Type
4.4 China Ipilimumab Sales and Market Share by Application

5 EUROPE IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Ipilimumab Sales and Value (2011-2016)
  5.1.1 Europe Ipilimumab Sales and Growth Rate (2011-2016)
  5.1.2 Europe Ipilimumab Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Ipilimumab Sales Price Trend (2011-2016)
5.2 Europe Ipilimumab Sales and Market Share by Manufacturers
5.3 Europe Ipilimumab Sales and Market Share by Type
5.4 Europe Ipilimumab Sales and Market Share by Application

6 JAPAN IPILIMUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Ipilimumab Sales and Value (2011-2016)
  6.1.1 Japan Ipilimumab Sales and Growth Rate (2011-2016)
  6.1.2 Japan Ipilimumab Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Ipilimumab Sales Price Trend (2011-2016)
6.2 Japan Ipilimumab Sales and Market Share by Manufacturers
6.3 Japan Ipilimumab Sales and Market Share by Type
6.4 Japan Ipilimumab Sales and Market Share by Application

7 GLOBAL IPILIMUMAB MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Ipilimumab Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Novartis
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 109 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Bayer
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 121 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Merck & Co.
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Exelixis
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview

8 IPILIMUMAB MAUFACTURING COST ANALYSIS

8.1 Ipilimumab Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Ipilimumab

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ipilimumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IPILIMUMAB MARKET FORECAST (2016-2021)

12.1 Global Ipilimumab Sales, Revenue Forecast (2016-2021)
12.2 Global Ipilimumab Sales Forecast by Regions (2016-2021)
12.3 Global Ipilimumab Sales Forecast by Type (2016-2021)
12.4 Global Ipilimumab Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ipilimumab
Table Classification of Ipilimumab
Figure Global Sales Market Share of Ipilimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Ipilimumab
Figure Global Sales Market Share of Ipilimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Ipilimumab Revenue and Growth Rate (2011-2021)
Figure China Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Europe Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Japan Ipilimumab Revenue and Growth Rate (2011-2021)
Figure Global Ipilimumab Sales and Growth Rate (2011-2021)
Figure Global Ipilimumab Revenue and Growth Rate (2011-2021)
Table Global Ipilimumab Sales of Key Manufacturers (2011-2016)
Table Global Ipilimumab Sales Share by Manufacturers (2011-2016)
Figure 2015 Ipilimumab Sales Share by Manufacturers
Figure 2016 Ipilimumab Sales Share by Manufacturers
Table Global Ipilimumab Revenue by Manufacturers (2011-2016)
Table Global Ipilimumab Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Ipilimumab Revenue Share by Manufacturers
Table 2016 Global Ipilimumab Revenue Share by Manufacturers
Table Global Ipilimumab Sales and Market Share by Type (2011-2016)
Table Global Ipilimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Ipilimumab by Type (2011-2016)
Figure Global Ipilimumab Sales Growth Rate by Type (2011-2016)
Table Global Ipilimumab Revenue and Market Share by Type (2011-2016)
Table Global Ipilimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ipilimumab by Type (2011-2016)
Figure Global Ipilimumab Revenue Growth Rate by Type (2011-2016)
Table Global Ipilimumab Sales and Market Share by Regions (2011-2016)
Table Global Ipilimumab Sales Share by Regions (2011-2016)
Figure Sales Market Share of Ipilimumab by Regions (2011-2016)
Figure Global Ipilimumab Sales Growth Rate by Regions (2011-2016)
Table Global Ipilimumab Revenue and Market Share by Regions (2011-2016)
Table Global Ipilimumab Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Ipilimumab by Regions (2011-2016)
Figure Global Ipilimumab Revenue Growth Rate by Regions (2011-2016)
Table Global Ipilimumab Sales and Market Share by Application (2011-2016)
Table Global Ipilimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Ipilimumab by Application (2011-2016)
Figure Global Ipilimumab Sales Growth Rate by Application (2011-2016)
Figure United States Ipilimumab Sales and Growth Rate (2011-2016)
Figure United States Ipilimumab Revenue and Growth Rate (2011-2016)
Figure United States Ipilimumab Sales Price Trend (2011-2016)
Table United States Ipilimumab Sales by Manufacturers (2011-2016)
Table United States Ipilimumab Market Share by Manufacturers (2011-2016)
Table United States Ipilimumab Sales by Type (2011-2016)
Table United States Ipilimumab Market Share by Type (2011-2016)
Table United States Ipilimumab Sales by Application (2011-2016)
Table United States Ipilimumab Market Share by Application (2011-2016)
Figure China Ipilimumab Sales and Growth Rate (2011-2016)
Figure China Ipilimumab Revenue and Growth Rate (2011-2016)
Figure China Ipilimumab Sales Price Trend (2011-2016)
Table China Ipilimumab Sales by Manufacturers (2011-2016)
Table China Ipilimumab Market Share by Manufacturers (2011-2016)
Table China Ipilimumab Sales by Type (2011-2016)
Table China Ipilimumab Market Share by Type (2011-2016)
Table China Ipilimumab Sales by Application (2011-2016)
Table China Ipilimumab Market Share by Application (2011-2016)
Figure Europe Ipilimumab Sales and Growth Rate (2011-2016)
Figure Europe Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Europe Ipilimumab Sales Price Trend (2011-2016)
Table Europe Ipilimumab Sales by Manufacturers (2011-2016)
Table Europe Ipilimumab Market Share by Manufacturers (2011-2016)
Table Europe Ipilimumab Sales by Type (2011-2016)
Table Europe Ipilimumab Market Share by Type (2011-2016)
Table Europe Ipilimumab Sales by Application (2011-2016)
Table Europe Ipilimumab Market Share by Application (2011-2016)
Figure Japan Ipilimumab Sales and Growth Rate (2011-2016)
Figure Japan Ipilimumab Revenue and Growth Rate (2011-2016)
Figure Japan Ipilimumab Sales Price Trend (2011-2016)
Table Japan Ipilimumab Sales by Manufacturers (2011-2016)
Table Japan Ipilimumab Market Share by Manufacturers (2011-2016)
Table Japan Ipilimumab Sales by Type (2011-2016)
Table Japan Ipilimumab Market Share by Type (2011-2016)
Table Japan Ipilimumab Sales by Application (2011-2016)
Table Japan Ipilimumab Market Share by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Ipilimumab Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ipilimumab Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Ipilimumab Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Ipilimumab Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Ipilimumab Global Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Ipilimumab Global Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Ipilimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Exelixis Ipilimumab Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ipilimumab
Figure Manufacturing Process Analysis of Ipilimumab
Figure Ipilimumab Industrial Chain Analysis
Table Raw Materials Sources of Ipilimumab Major Manufacturers in 2015
Table Major Buyers of Ipilimumab
Table Distributors/Traders List
Figure Global Ipilimumab Sales and Growth Rate Forecast (2016-2021)
Figure Global Ipilimumab Revenue and Growth Rate Forecast (2016-2021)
Table Global Ipilimumab Sales Forecast by Regions (2016-2021)
Table Global Ipilimumab Sales Forecast by Type (2016-2021)
Table Global Ipilimumab Sales Forecast by Application (2016-2021)